Our Mission

Clara Biotech’s mission is to enable tomorrow’s medical breakthroughs in exosomes today by solving the critical issues of purification and isolation. Removing these two roadblocks will open the door for diagnostic and therapeutic advances ranging from 

Therapeutics applications like:

​

• Personalized medicine

• Targeted drug delivery

• Immunotherapy

• Orphan & Rare Diseases

Liquid Biopsy Diagnostics and

Biomarker Discovery like:

​

• Early cancer detection; 

• Alzheimer’s Disease; 

• Virus detection

With the goal of making these possibilities a reality, Clara Biotech was founded in 2018. The team is dedicating its 50+ years of combined experience to addressing the critical manufacturing challenges keeping exosome solutions from reaching the patients who need them most.

Despite exosomes being discovered less than ten years ago, in the last year more than 20% of all research in the field has been developed. However, every exosome researcher runs into the same problem: lack of standardization around a simple, reliable isolation method. 

Just as the exosome industry is expanding, Clara Biotech is expanding its services to provide an in-lab isolation kit. Interested labs can apply for early access and become one of the first to bring this groundbreaking technology in-house. 

So, how does it work? Let us explain.